Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
12/29/2010 | EP2266978A1 Novel physiologically active substances |
12/29/2010 | EP2266960A2 Aryl-substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles as anticonvulsants |
12/29/2010 | EP2266948A1 Salts of tramadol and diflunisal and their crystal form in the treatment of pain |
12/29/2010 | EP2266665A1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
12/29/2010 | EP2266626A1 Composition for external application comprising transcription factor decoy as active ingredient |
12/29/2010 | EP2266624A2 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections |
12/29/2010 | EP2266575A2 Use of Norgestimate as a selective inhibitor of TRPC3, TRPC6 and TRPC7 ion channels |
12/29/2010 | EP2266557A1 Method of utilization of combination of benzophenone derivative or salt thereof and immunosuppressing agent, and pharmaceutical composition comprising these components |
12/29/2010 | EP2266556A1 Water-based adhesive skin patch comprising ketoprofen lysine salt |
12/29/2010 | EP2266551A1 Compositions and kits comprising a defined boron compound and methods of their preparation |
12/29/2010 | EP2266547A1 Composition for the transdermal delivery of fentanyl |
12/29/2010 | EP2266542A2 Controlled release nanoparticulate compositions |
12/29/2010 | EP2265591A1 Nitrone compounds, process of preparation thereof, and use thereof in medicament manufacture |
12/29/2010 | EP2265584A1 Hydroxyalkanyl amides as modulators of chemokine receptor activity |
12/29/2010 | EP2265288A1 Methods of treating inflammatory pain |
12/29/2010 | EP2265287A1 Methods of treating chronic pain |
12/29/2010 | EP2265265A2 Treatment of inflammatory conditions and diseases with metal-thiols |
12/29/2010 | EP2265124A1 Aerosolized lfa-1 antagonists for use in localized treatment of immune related disorders |
12/29/2010 | EP2104535B1 Compounds and compositions as channel activating protease inhibitors |
12/29/2010 | EP2069341B1 Pyrrolo[2, 3-b]pyridin-4-yl-benzenesulfonamide compounds as ikk2 inhibitors |
12/29/2010 | EP1940826B1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
12/29/2010 | EP1861377B1 Benzimidazolone derivatives as cb2 receptor ligands |
12/29/2010 | EP1856153B1 Ykl-40 monoclonal antibodies |
12/29/2010 | EP1530568B1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE |
12/29/2010 | EP1438052B1 Quinazolin-4-ones as inhibitors of human phosphatidylinositol 3-kinase delta |
12/29/2010 | EP1404312B1 Carbamate compounds for use in the treatment of pain |
12/29/2010 | EP1197209B1 Percutaneously absorbable preparations |
12/29/2010 | EP1183022B1 Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response |
12/29/2010 | EP1001946B1 QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES |
12/29/2010 | CN1968691B Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis |
12/29/2010 | CN1956707B Gastroresistant pharmaceutical dosage form comprising N-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-D-glutamic acid (LK-423) |
12/29/2010 | CN1922139B Bicyclic amide derivatives |
12/29/2010 | CN101932608A Antigen-binding constructs |
12/29/2010 | CN101932571A Compounds having crth2 antagonist activity |
12/29/2010 | CN101932329A Adhesive patch |
12/29/2010 | CN101932316A Pharmaceuticals and the production and use thereof in the treatment of painful neuropathies |
12/29/2010 | CN101928287A Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same |
12/29/2010 | CN101928284A Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient |
12/29/2010 | CN101928279A 3-amino-2-pyrones cyclooxygenase inhibitors as well as preparation method and application thereof |
12/29/2010 | CN101928262A Biologically active methylene blue derivatives |
12/29/2010 | CN101928259A 2-arylthiazole derivative and medicament composition thereof |
12/29/2010 | CN101928234A 6/7-(hetero)aryl-N-hydroxyl hexanamide/heptamide compounds and method for preparing same |
12/29/2010 | CN101928227A Mutual prodrug of 6-methoxyl-2-naphthylacetic acid and salicylanilide compounds, preparation method and application thereof |
12/29/2010 | CN101928214A Method for synthesizing dexketoprofen trometamol |
12/29/2010 | CN101926977A Medicament for expelling wind, removing dampness, activating blood and relieving pain |
12/29/2010 | CN101926957A Medicinal composition for treating arthralgia syndrome and preparation method thereof |
12/29/2010 | CN101926943A Method for preparing burn and scald pain killing band-aid |
12/29/2010 | CN101926939A Chinese medicinal preparation for treating rheumatic diseases |
12/29/2010 | CN101926926A Traditional Chinese medicinal preparation for treating rheumatic arthritis and chronic infectious arthritis |
12/29/2010 | CN101926920A Traditional Chinese medicine composition for treatment of rheumatoid arthritis and preparation method thereof |
12/29/2010 | CN101926911A Chinese medicinal composition for relieving pain and preparation method thereof |
12/29/2010 | CN101926908A Chinese medicinal composition for treating cold |
12/29/2010 | CN101926904A Medicinal liquor for treating rheumatic arthralgia and osteoarthrosis |
12/29/2010 | CN101926900A Pediluvium composition and preparing method thereof |
12/29/2010 | CN101926888A Externally-applied medicament for treating gout |
12/29/2010 | CN101926885A Far infrared rheumatism patch |
12/29/2010 | CN101926863A Method for identifying Nigella glandulifera Freyn medicinal material |
12/29/2010 | CN101926860A Peony extract-methotrexate composition, preparation method thereof and use thereof |
12/29/2010 | CN101926847A External solid ointment containing mint oil |
12/29/2010 | CN101926837A Preparation method of kalopanax septemlobus leaf total effective part and medical application thereof |
12/29/2010 | CN101926833A Hydrogel patch and preparation method thereof |
12/29/2010 | CN101926826A Method for extracting active ingredients from sea horse |
12/29/2010 | CN101926815A Paeoniflorin and glycyrrhetinic acid composition and preparation method and application thereof |
12/29/2010 | CN101926811A Triterpenoid saponin total extract of Chinese starjasmine stem and preparation method and application thereof |
12/29/2010 | CN101926808A Glucosamine formulations |
12/29/2010 | CN101926805A Pharmaceutical composition containing 16, 17 isoxazolidine steroidal compound |
12/29/2010 | CN101926802A Application of quinazoline compounds |
12/29/2010 | CN101926772A Polysaccharide nucleic acid fraction of bacillus calmette guerin lipid composition for livestock and freeze-dry preparation thereof |
12/29/2010 | CN101926769A Dexamethasone sodium phosphate lipidosome injection |
12/29/2010 | CN101926763A Method for preparing lipoalprostadil sterile preparation |
12/29/2010 | CN101926760A Dexamethasone injecta coated with 2-hydroxypropyl-beta-cyclodextrin |
12/29/2010 | CN101926755A In-situ gel preparation of potassium dehydroandrographolide succinate and preparation method thereof |
12/29/2010 | CN101658526B Veterinary compound enrofloxacin injection and preparation method thereof |
12/29/2010 | CN101445504B Dioxane-2-alkyl carbamates derivatives |
12/29/2010 | CN101417082B Traditional Chinese medicine combination for treating rheumatic heart disease |
12/29/2010 | CN101411702B Nefopam hydrochloride naproxen sodium compound sustained-release preparation and preparation method thereof |
12/29/2010 | CN101406591B Plaster for treating sore, carbuncle and painful swelling and preparation method thereof |
12/29/2010 | CN101401930B Polypeptide and uses in preparing anti-heart failure and anti-inflammatory reaction medicament |
12/29/2010 | CN101278934B Oral soft capsule compound preparations for curing cold |
12/29/2010 | CN101244181B Plaster for bone paralysis with function of qufengshengshi, blood circulation activating and stasis removing, and removing the obstruction in the channels to relieve pain, and preparation thereof |
12/29/2010 | CN101214309B Medicament for treating chronic colon/rectum mucous membrane inflammation |
12/29/2010 | CN101209288B Corydalis decumbentis orally disintegrating tablets |
12/29/2010 | CN101190289B Traditional Chinese medicine for treating combined hemorrhoid postoperative edema pain |
12/29/2010 | CN101077110B Health-care tea and its making method |
12/29/2010 | CA2784286A1 Urate transporter, method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug |
12/29/2010 | CA2766521A1 Albumin-free botulinum toxin formulations |
12/29/2010 | CA2766048A1 Novel acetylsalicylic acid salts |
12/29/2010 | CA2765988A1 Novel compound useful for the treatment of degenerative and inflammatory diseases |
12/29/2010 | CA2765823A1 Tricyclic heterocyclic compounds as mediators of p13k activity |
12/29/2010 | CA2765819A1 Heterocyclic compounds and their uses as inhibitors of p13 k activity |
12/29/2010 | CA2765817A1 Heterocyclic compounds and their uses |
12/29/2010 | CA2764963A1 Method for treating a patient at risk for developing an nsaid-associated ulcer |
12/29/2010 | CA2761921A1 Novel indole, indazole and benzimidazole arylamides |
12/28/2010 | USRE42014 Pharmaceutical compositions |
12/28/2010 | US7858824 Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing them |
12/28/2010 | US7858738 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
12/28/2010 | US7858665 1-[4-(nitrooxymethyl)benzoylaminomethyl]-cyclohexaneacetic acid; neurophatic pain |
12/28/2010 | US7858641 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes |
12/28/2010 | US7858631 such as (3R,5S)-N-(3-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-7-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used as melanocortin-4 receptor (MC4-R) agonists, for the treatment of obesity or diabetes |
12/28/2010 | US7858577 Use of the long pentraxin PTX3 for the treatment of diseases caused by an altered activation of the growth factor FGF-2 |